BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18498187)

  • 1. Osteogenesis imperfecta collagen-like peptides: self-assembly and mineralization on surfaces.
    Xu P; Huang J; Cebe P; Kaplan DL
    Biomacromolecules; 2008 Jun; 9(6):1551-7. PubMed ID: 18498187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid sequence environment modulates the disruption by osteogenesis imperfecta glycine substitutions in collagen-like peptides.
    Yang W; Battineni ML; Brodsky B
    Biochemistry; 1997 Jun; 36(23):6930-5. PubMed ID: 9188687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance shows asymmetric loss of triple helix in peptides modeling a collagen mutation in brittle bone disease.
    Liu X; Kim S; Dai QH; Brodsky B; Baum J
    Biochemistry; 1998 Nov; 37(44):15528-33. PubMed ID: 9799516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site.
    Radmer RJ; Klein TE
    Biochemistry; 2004 May; 43(18):5314-23. PubMed ID: 15122897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic collagen heterotrimers: structural mimics of wild-type and mutant collagen type I.
    Gauba V; Hartgerink JD
    J Am Chem Soc; 2008 Jun; 130(23):7509-15. PubMed ID: 18481852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine.
    Beck K; Chan VC; Shenoy N; Kirkpatrick A; Ramshaw JA; Brodsky B
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4273-8. PubMed ID: 10725403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations.
    Bodian DL; Madhan B; Brodsky B; Klein TE
    Biochemistry; 2008 May; 47(19):5424-32. PubMed ID: 18412368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular assembly of collagen triblock peptides.
    Martin R; Waldmann L; Kaplan DL
    Biopolymers; 2003 Dec; 70(4):435-44. PubMed ID: 14648755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen.
    Bächinger HP; Morris NP; Davis JM
    Am J Med Genet; 1993 Jan; 45(2):152-62. PubMed ID: 8456797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P; Schott AM; Prockop D; Chevrel G
    Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
    Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
    Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear magnetic resonance characterization of peptide models of collagen-folding diseases.
    Buevich A; Baum J
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):159-68. PubMed ID: 11260796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model.
    Kuznetsova NV; Forlino A; Cabral WA; Marini JC; Leikin S
    Matrix Biol; 2004 May; 23(2):101-12. PubMed ID: 15246109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free energy simulation to investigate the effect of amino acid sequence environment on the severity of osteogenesis imperfecta by glycine mutations in collagen.
    Lee KH; Holl MM
    Biopolymers; 2011 Jun; 95(6):401-9. PubMed ID: 21280025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence environment of mutation affects stability and folding in collagen model peptides of osteogenesis imperfecta.
    Bryan MA; Cheng H; Brodsky B
    Biopolymers; 2011; 96(1):4-13. PubMed ID: 20235194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folding of peptide models of collagen and misfolding in disease.
    Baum J; Brodsky B
    Curr Opin Struct Biol; 1999 Feb; 9(1):122-8. PubMed ID: 10047579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-complementary peptides for the formation of collagen-like triple helical supramolecules.
    Koide T; Homma DL; Asada S; Kitagawa K
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5230-3. PubMed ID: 16185864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple-helical peptides: an approach to collagen conformation, stability, and self-association.
    Brodsky B; Thiagarajan G; Madhan B; Kar K
    Biopolymers; 2008 May; 89(5):345-53. PubMed ID: 18275087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical Assembly of Collagen-Like Peptides in vitro Provides Structural Causes of Osteogenesis Imperfecta.
    Huang J; Cebe P; Kaplan DL
    Macromol Rapid Commun; 2009 Feb; 30(4-5):336-44. PubMed ID: 21706609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.